Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-16

Colgate Palmolive Co (CL) Stock Forecast Oct. 16, 2026

Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · NYSE

Follow Unlock full AI forecasts
Rating · 90D ▼ Bearish Exact rating locked
90-day forecast Sign up free to reveal
30-day forecast Total
Rank in coverage Bottom 35% of 5172 stocks scored
Rank correlation · 90D -2.0% Spearman, 357 dates
Market Cap $75.02B large-cap · #1 of 19 peers
Summary

Colgate Palmolive Co (CL) stock forecast summary

Our AI ranks Colgate Palmolive Co outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

Colgate Palmolive Co is a large-cap company with a market capitalization of $75.02B. It ranks number 1 by market capitalization among the 19 Perfumes, Cosmetics & Other Toilet Preparations issuers in our coverage with a current forecast. Its P/B Ratio of 317.89x is the highest of the 14 peers that report one. Its ROE of 863.6% is the highest of the 13 peers that report one.

For CL, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -2.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -19.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.0%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, CL included.

Follow CL free
Price

CL price chart and AI forecast

CL
Cross-section · 2026-10-16

How CL ranks among 5172 stocks

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals · 2026-06-30

Colgate Palmolive Co (CL) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Perfumes, Cosmetics & Other Toilet Preparations peers listed below that report each metric.

Valuation & Market

MetricCLIndustry medianRank
Market Cap $75.02B $96M 1/19
P/E Ratio 36.48x 23.18x 3/8
P/B Ratio 317.89x 2.71x 1/14
Dividend Yield 2.43% 2.32% 3/6
EPS $2.58 – –
Book Value/Share $0.30 – –
Revenue/Share $26.40 – –
FCF/Share $4.84 – –

Profitability & Margins

MetricCLIndustry medianRank
ROE 863.6% 4.8% 1/13
ROA 12.1% -2.6% 3/15
ROIC 29.4% 6.0% 1/13
Gross Margin 60.4% 58.2% 7/15
Operating Margin 14.9% 2.6% 5/16
Net Margin 9.7% -1.1% 4/14
EBT Margin 14.0% 0.2% 5/16
Tax Rate 26.5% – –

Financial Health

MetricCLIndustry medianRank
Current Ratio 1.03x 1.70x 12/17
Quick Ratio 0.67x 0.97x 15/17
D/E Ratio 68.75x 1.11x 1/15
Financial Leverage 71.14x 2.11x 1/15
Interest Coverage 8.0x 1.5x 4/13
Working Capital $160M $11M 6/17

Cash Flow

MetricCLIndustry medianRank
Operating Cash Flow $4.46B $4M 2/18
Free Cash Flow $3.86B $263M 2/12
Capital Spending -$598M -$43M 11/12
OCF Growth YoY 13.7% 15.4% 6/10
FCF Growth YoY 14.5% 23.0% 9/10
FCF/Sales 18.3% 13.5% 2/12
CapEx/Sales 2.8% 2.2% 4/12

Operational Efficiency

MetricCLIndustry medianRank
Asset Turnover 1.25x 0.82x 4/15
Receivables Turnover 10.7x 10.7x 7/13
Inventory Turnover 3.8x 3.0x 5/14
Fixed Assets Turnover 4.5x 10.1x 13/14
Days Sales Outstanding 34 days 34 days 7/13
Days Inventory 96 days 107 days 9/14
Payables Period 93 days 69 days 4/13
Cash Conversion Cycle 37 days 89 days 8/12

Income Statement

MetricCLIndustry medianRank
Total Revenue $21.05B $1.50B 2/15
Operating Income $3.13B $0.00M 2/17
Net Income $2.04B $0.00M 1/15
SG&A Expense $8.25B $699M 3/13
Cost of Goods Sold $8.33B $255M 2/16

Dividend & Shareholder Information

MetricCLIndustry medianRank
Dividends Per Share $2.29 – –
Payout Ratio 88.8% – –
Shares Outstanding 797M – –
Net Income Growth -29.9% -16.8% 5/8
EPS Growth -26.9% -26.9% 4/7

Balance Sheet Highlights (USD millions)

Total Current Assets$6.31B37.6% of assets
Cash & Short-term Investments$1.37B8.2% of assets
Accounts Receivable$1.96B11.7% of assets
Inventory$2.18B13.0% of assets
Total Liabilities$16.22B96.6% of assets
Short-term Debt$4.03B24.0% of assets
Quarterly Financial Reports

CL quarterly financials and insider trading

Industry Peers · Perfumes, Cosmetics & Other Toilet Preparations

Colgate Palmolive Co (CL) industry peers

Companies classified under the same SEC industry code as Colgate Palmolive Co (Perfumes, Cosmetics & Other Toilet Preparations): 19 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Total) Market Cap P/E Ratio P/B Ratio
CL Colgate Palmolive Co ▼ $75.02B 36.5x 317.9x
HLN Haleon Plc ▼ $44.72B 14.5x –
EL Estee Lauder Companies Inc ▶ $37.82B 209.1x 9.9x
KVUE Kenvue Inc. ▼ $36.32B 24.2x 3.4x
ELF E.L.F. Beauty, Inc. ▶ $6.70B 115.9x 5.7x
IPAR Interparfums Inc ▶ $3.71B 22.1x 4.3x
COTY Coty Inc. ▲ $2.82B – 0.9x
EPC Edgewell Personal Care Co ▼ $1.29B – 0.9x
ODD Oddity Tech Ltd ▲ $1.03B – 2.6x
WALD Waldencast Plc ▲ $96M – 0.2x
SLSN Solesence, Inc. ▲ $63M – 4.8x
SHFH Scientist Home Future Health Ltd ▼ $40M – –
AXIL Axil Brands, Inc. ▶ $37M 16.1x 2.7x
UG United Guardian Inc ▶ $31M 12.8x 2.7x
DQWS Dswiss Inc ▼ $17M – –
KARX Karbon-X Corp. ▼ $17M – –
CABR Caring Brands, Inc. ▶ $13M – –
BNKK Bonk, Inc. ▶ $10M – 0.4x
YCBD Cbdmd, Inc. ▲ $4M – 0.5x

Where CL sits on the market map

Industrial Applications and Services · Perfumes, Cosmetics & Other Toilet Preparations
Explore the map →
News

Colgate Palmolive Co (CL) stock news

Loading...

FAQ

Colgate Palmolive Co (CL) stock forecast FAQ

What is the Colgate Palmolive Co (CL) stock forecast?

Our AI ranks Colgate Palmolive Co outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

How accurate are Colgate Palmolive Co stock predictions?

For CL, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -2.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -19.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Colgate Palmolive Co forecasts updated?

Colgate Palmolive Co forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.

Which companies are Colgate Palmolive Co's industry peers?

19 issuers in our coverage, CL included, share the SEC industry code Perfumes, Cosmetics & Other Toilet Preparations. The largest are: Haleon Plc (HLN), Estee Lauder Companies Inc (EL), Kenvue Inc. (KVUE), E.L.F. Beauty, Inc. (ELF), Interparfums Inc (IPAR), Coty Inc. (COTY).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.